share_log

Guggenheim Initiates Coverage On Boundless Bio With Buy Rating, Announces Price Target of $24

Guggenheim Initiates Coverage On Boundless Bio With Buy Rating, Announces Price Target of $24

古根海姆以買入評級啓動對Boundless Bio的報道,宣佈目標股價爲24美元
Moomoo 24/7 ·  04/22 07:18

Guggenheim analyst Yige Guo initiates coverage on Boundless Bio (NASDAQ:BOLD) with a Buy rating and announces Price Target of $24.

古根海姆分析師郭義歌開始對Boundless Bio(納斯達克股票代碼:BOLD)進行報道,評級爲買入,並宣佈目標股價爲24美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論